Pharmaceutical Retailers
SCNX
7.46
price up icon1.91%   0.14
after-market Handel nachbörslich: 7.46

Scienture Holdings Inc (SCNX)
full-star
loading
Überblick Nachrichten Preisverlauf Forum Prognose
Schlusskurs vom Vortag:
$7.32
Offen:
$6.8992
24-Stunden-Volumen:
10,872
Relative Volume:
18.05
Marktkapitalisierung:
$13.06M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.00%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$6.8992
$7.46
1-Wochen-Bereich:
Value
$6.8992
$7.6411
52-Wochen-Spanne:
Value
$6.8992
$7.6411

Scienture Holdings Inc Stock (SCNX) Company Profile

Name
Firmenname
Scienture Holdings Inc
Name
Sektor
Healthcare (1190)
Name
Branche
Pharmaceutical Retailers (9)
Name
Telefon
(800) 261 0281
Name
Adresse
2420 BRUNELLO TRACE, LUTZ
Name
Mitarbeiter
8
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
SCNX's Discussions on Twitter

Scienture Holdings Inc Aktie (SCNX) Neueste Nachrichten

pulisher
Sep 24, 2024

Scienture Holdings Unveils New Identity Post-Merger - TipRanks

Sep 24, 2024
pulisher
Sep 24, 2024

TRxADE Health rebrands as Scienture Holdings with new ticker SCNX - Investing.com

Sep 24, 2024
pulisher
Sep 24, 2024

SCNXScienture Holdings, Inc. Latest Stock News & Market Updates - StockTitan

Sep 24, 2024
pulisher
Sep 20, 2024

Trxade Health announces name change to Scienture Holdings - TipRanks

Sep 20, 2024
pulisher
Sep 20, 2024

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. - StockTitan

Sep 20, 2024
pulisher
Jul 29, 2024

TRxADE HEALTH completes all-stock merger deal with Scienture - World Pharmaceutical Frontiers

Jul 29, 2024
pulisher
Jul 26, 2024

$103M all-stock transaction merges TRxADE and Scienture, forming new company - Investing.com

Jul 26, 2024
pulisher
Jun 27, 2024

TRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income Due to Asset Sale - StockTitan

Jun 27, 2024
pulisher
Jun 25, 2024

Alumis looks to raise $300 million in IPO. Here’s what you need to know - AlphaStreet

Jun 25, 2024
pulisher
Apr 04, 2024

Femasys is committed to providing women with revolutionary healthcare products: CEO - AlphaStreet

Apr 04, 2024
pulisher
Dec 10, 2023

Nordic Group makes another acquisition to diversify earnings base - Yahoo Finance

Dec 10, 2023
pulisher
Sep 04, 2023

symbol__ Stock Quote Price and Forecast - CNN

Sep 04, 2023
pulisher
Apr 11, 2023

Continued focus on core B2B segment drives new business: Trxade CEO Suren Ajjarapu - AlphaStreet

Apr 11, 2023
pulisher
May 23, 2022

Trxade (MEDS) is increasing the breadth of product offerings: CEO Suren Ajjarapu - AlphaStreet

May 23, 2022
pulisher
Jul 29, 2020

No concerns on margin side: Trxade (MEDS) CEO Suren Ajjarapu - AlphaStreet

Jul 29, 2020
pulisher
Feb 17, 2020

MEDS Stock Price and Chart — NASDAQ:MEDS - TradingView

Feb 17, 2020
pulisher
Dec 23, 2014

Trxade Group, Inc. Elects Donald Almeida to Board of Directors - Marketscreener.com

Dec 23, 2014

Finanzdaten der Scienture Holdings Inc-Aktie (SCNX)

Es liegen keine Finanzdaten für Scienture Holdings Inc (SCNX) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie SCNX

pharmaceutical_retailers CJJD
$1.79
price up icon 5.36%
pharmaceutical_retailers SSY
$0.8707
price up icon 8.84%
pharmaceutical_retailers LFMDP
$22.50
price down icon 1.32%
pharmaceutical_retailers GRDN
$17.75
price up icon 10.94%
pharmaceutical_retailers PETS
$3.68
price up icon 1.10%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | Open in MarketWatch | Open in EDGAR | Open in Reuters
Kapitalisierung:     |  Volumen (24h):